Asquith Israel Merchant Bank introduces AIMB Series 1
Category: Investing
Asquith Israel is poised to make its first investments in selected, revenue-generating Israeli companies.
Asquith Israel invests in and supports selected Israeli growth companies with two core goals – a healthy return for investors, and driving Israel’s next phase of development by strengthening the SME (small and medium-sized enterprise) sector.
Investing in any kind of private equity or select fund carries some degree of risk, which presents a challenge in the current risk-averse environment; a direct investment in Asquith Israel may not be eligible for consideration by many institutional investors.
In response to these factors, Asquith Israel has created a special purpose vehicle (SPV) so that investors can have prior visibility of the first five investment opportunities, and have their funds deployed directly and immediately into them. This represents Series I.
Series II will be launched in Q2 of 2012, and funds will be custodied and managed by Asquith Israel. Investors in Series I will have priority investment rights in this, as well as priority co-investment rights in any Series I company.
The companies selected for inclusion in Series I reflect some of Israel’s innovation strengths: high-tech, water technology, medical devices and security. All the businesses are revenue-producing or will be in 2012, and Asquith Israel is already providing substantial advisory support to all, to ensure business development, co-investment and strategic direction.
Investors are invited to work with Asquith Israel to participate actively in business development activities in investee companies where appropriate.
For more information or for an introduction to Asquith Ventures, please contact Steven Slivnick with the Government of Israel Economic Mission to the Midwest at steven.slivnick@israeltrade.gov.il.
Contact information
Name: Asquith Merchant Bank
Phone: +972 (0)3 721 9658
Email: michael@asquithisrael.com
Website: www.asquithisrael.com
Contact Person: Michael Freedman
